$GMAB news
The latest GMAB stock news: headlines, filings, AI summaries and sentiment for $GMAB, updated around the clock.
- Genmab Reports Strong Q3 2026 Growth Driven by DARZALEX and EPKINLY Sales
- Genmab Shares Double Following Three Successful Phase 3 Cancer Drug Trials
- Genmab Shares Surge Following Positive Phase 3 Trial Results for Petosemtamab
- Genmab and AbbVie Report Positive Phase 3 Trial Results for Epkinly in B-cell Lymphoma
- Genmab Raises Full-Year Revenue Guidance Amid Strong Royalty Growth
- AbbVie and Genmab Report Late-Stage Trial Failure for Lymphoma Drug Epcoritamab
- EU Expands Label for AbbVie and Genmab's Tepkinly in Blood Cancer Treatment
- Goldman Sachs Upgrades Genmab A/S to Buy on Positive 2026 Outlook